20.01.2019, 1533 Zeichen

Valneva: Austrian French Biotech company Valneva announced the signing of a new USD 59 mn contract with the U.S. government Department of Defense for the supply of its Japanese encephalitis (JE) vaccine IXIARO®. Under the terms of the agreement, Valneva will supply IXIARO® doses to the Defense Logistics Agency of the U.S. Department of Defense, through 2019 and the beginning of 2020 with a value of USD 59 mn guaranteed and potentially worth up to USD 70 mn. A delivery schedule is being prepared and supply shipments will commence immediately.
Valneva: weekly performance: 6.51%

Verbund: Austrian utility company Verbund announced an increase in earnings forecast for financial year 2018. As a result of positive non-recurring effects from impairment testing, the company now expects a Group result of approximately Euro 430 mn for financial year 2018 (former forecast: approximately Euro 340 million). The forecast for EBITDA and the Group result adjusted for non-recurring effects, which serves as the basis for calculating the dividend, remains unchanged at approximately Euro 870 mn and approximately Euro 335 mn respectively. A favourable change in parameters in the energy market, primarily an increase in electricity price forecasts, caused these positive non-recurring effects from impairment testing. The resulting value increases concern hydropower in Austria and Germany and wind energy in Romania.
Verbund: weekly performance: 5.22%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (16/01/2019)

Christian Drastil: Wiener Börse Plausch

Wiener Börse Party #1210: ATX dank sehr starker Andritz (+Spoiler) fester, Österreichische Bundesfinanzierungsagentur zu Gast

Bildnachweis

Aktien auf dem Radar:Kapsch TrafficCom, Palfinger, Lenzing, Austriacard Holdings AG, Semperit, CPI Europe AG, CA Immo, VIG, Fabasoft, Strabag, EVN, Amag, Andritz, AT&S, Bawag, FACC, Marinomed Biotech, RBI, BKS Bank Stamm, DO&CO, EuroTeleSites AG, Österreichische Post, Telekom Austria, UBM, ATX.

---